Elahere for ovarian cancer
WebNov 15, 2024 · The Food and Drug Administration (FDA) granted an accelerated approval to Elahere (mirvetuximab soravtansine-gynx) for the treatment of patients with folate receptor alpha (FRα)-positive platinum … WebELAHERE is a folate receptor alpha (FRα)-directed antibody and microtubule inhibitor conjugate indicated for the treatment of adult patients with FR α positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received one to three prior systemic treatment regimens.
Elahere for ovarian cancer
Did you know?
Web2 days ago · While Elahere is approved for FRα-high patients, representing 35-40% of the ovarian cancer population, Sutro has argued that STRO-002 has shown strong activity in >25% FRα expressers, accounting ... WebJan 17, 2024 · Elahere is approved for adults with FR-α-positive, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer who have undergone one to three prior systemic treatment regimens. "Importantly, Elahere is indicated in a subset of ovarian cancer patients, those whose tumors overexpress FR-α," Labidi-Galy said.
WebDec 12, 2024 · Mirvetuximab soravtansine (Elahere) for ovarian, fallopian tube, and primary peritoneal cancer. ... (Elahere) for ovarian, fallopian tube, and primary peritoneal cancer. Mirvetuximab soravtansine (Elahere) for ovarian, fallopian tube, and primary peritoneal cancer Med Lett Drugs Ther. 2024 Dec 12;64(1665):e205-e206. PMID: … WebFRα is an actionable target with the approval of ELAHERE ™ (mirvetuximab soravtansine-gynx), a FDA-approved FRα—targeting antibody drug conjugate (ADC) for platinum-resistant ovarian cancer. It is important to test all ovarian cancer patients for …
WebElahere (mirvetuximab soravtansine) becomes the first FDA-approved antibody drug conjugate for platinum-resistant disease. It also is the first approval in eight years for advanced ovarian... WebApr 7, 2024 · There are key side effects that patients should be aware of when taking Elahere (mirvetuximab soravtansine-gynx) — an antibody drug conjugate that, in November 2024, gained FDA approval for patients with platinum-resistant ovarian cancer — according to Dr. Ursula A. Matulonis, chief of the division of gynecologic oncology and the Brock …
WebApr 10, 2024 · Ovarian Cancer. Prostate Cancer. Melanoma & Skin Cancer. MCL. MPN. CAR T-cell Therapy. Chronic Lymphocytic Leukemia. Gynecologic Oncology. ... (Elahere) in the phase 3 SORAYA trial (NCT04296890 ...
WebELAHERE is a prescription medicine used to treat adults with folate receptor-alpha positive ovarian cancer, fallopian tube cancer, or primary peritoneal cancer who: have not … thinkers and teachers of hinduismWebELAHERE was studied in a clinical trial of 106 people with FR α-positive, platinum-resistant ovarian cancer, fallopian tube cancer, or primary ... ELAHERE can cause serious side effects, including: Eye problems. Eye problems are common with ELAHERE and can also be severe. Tell your healthcare provider right away if you develop any eye problems ... thinkers barWebDec 12, 2024 · ELAHERE™ (mirvetuximab soravtansine-gynx), FDA Approved for Platinum-Resistant Ovarian Cancer, Available at Biologics by McKesson McKesson Newsroom Press Releases Share ELAHERE™ (mirvetuximab soravtansine-gynx), FDA Approved for Platinum-Resistant Ovarian Cancer, Available at Biologics by McKesson December 12, … thinkers appWebAdvanced ovarian cancer is cancer that has spread outside the ovary. It can spread within the pelvis or abdomen or further away to other body parts, such as the lungs. With the development of innovative targeted treatments, immunotherapies, and combination therapies and the rise of precision medicine, the advanced ovarian cancer market has ... thinkers arranging beer in lineWeb1 day ago · As part of the phase 3 GLORIOSA study (NCT05445778), a clinical trial is evaluating the safety and efficacy of the antibody drug conjugate (ADC) mirvetuximab soravtansine (Elahere) as maintenance therapy for patients with folate receptor-alpha (FRα)-positive recurrent platinum-sensitive ovarian cancer. 1 In the multicenter, open … thinkers associated with gender issuesWebELAHERE is a prescription medicine used to treat adults with folate receptor-alpha positive ovarian cancer, fallopian tube cancer, or primary peritoneal cancer who: … thinkers and feelers myers briggsWebELAHERE is a folate receptor alpha (FRα)-directed antibody and microtubule inhibitor conjugate indicated for the treatment of adult patients with FRα positive, platinum … thinkers associated with political theory